Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Megan E Carey,Zoe A Dyson,Danielle J Ingle,Afreenish Amir,Mabel K Aworh,Marie Anne Chattaway,Ka Lip Chew,John A Crump,Nicholas A Feasey,Benjamin P Howden,Karen H Keddy,Mailis Maes,Christopher M Parry,Sandra Van Puyvelde,Hattie E Webb,Ayorinde Oluwatobiloba Afolayan,Anna P Alexander,Shalini Anandan,Jason R Andrews,Philip M Ashton,Basnyat,Ashish Bavdekar,Isaac I Bogoch,John D Clemens,Kesia Esther da Silva,Anuradha De,Joep de Ligt,Paula Lucia Diaz Guevara,Christiane Dolecek,Shanta Dutta,Marthie M Ehlers,Louise Francois Watkins,Denise O Garrett,Gauri Godbole,Melita A Gordon,Andrew R Greenhill,Chelsey Griffin,Madhu Gupta,Rene S Hendriksen,Robert S Heyderman,Yogesh Hooda,Juan Carlos Hormazabal,Odion O Ikhimiukor,Junaid Iqbal,Jobin John Jacob,Claire Jenkins,Dasaratha Ramaiah Jinka,Jacob John,Gagandeep Kang,Abdoulie Kanteh,Arti Kapil,Abhilasha Karkey,Samuel Kariuki,Robert A Kingsley,Roshine Mary Koshy,AC Lauer,Myron M Levine,Ravikumar Kadahalli Lingegowda,Stephen P Luby,Grant Austin Mackenzie,Tapfumanei Mashe,Chisomo Msefula,Ankur Mutreja,Geetha Nagaraj,Savitha Nagaraj,Satheesh Nair,Take K Naseri,Susana Nimarota-Brown,Elisabeth Njamkepo,Iruka N Okeke,Sulochana Putli Bai Perumal,Andrew J Pollard,Agila Kumari Pragasam,Firdausi Qadri,Farah N Qamar,Sadia Isfat Ara Rahman,Savitra Devi Rambocus,David A Rasko,Pallab Ray,Roy Robins-Browne,Temsunaro Rongsen-Chandola,Jean Pierre Rutanga,Samir K Saha,Senjuti Saha,Karnika Saigal,Mohammad Saiful Islam Sajib,Jessica C Seidman,Jivan Shakya,Varun Shamanna,Jayanthi Shastri,Rajeev Shrestha,Sonia Sia,Michael J Sikorski,Ashita Singh,Anthony M Smith,Kaitlin A Tagg,Dipesh Tamrakar,Arif Mohammed Tanmoy,Maria Thomas,Mathew S Thomas,Robert Thomsen,Nicholas R Thomson,Siaosi Tupua,Krista Vaidya,Mary Valcanis,Balaji Veeraraghavan,François-Xavier Weill,Jackie Wright,Gordon Dougan,Silvia Argimón,Jacqueline A Keane,David M Aanensen,Stephen Baker,Kathryn E Holt,Peter Aaby,Ali Abbas,Niyaz Ahmed,Saadia Andleeb,Abraham Aseffa,Kate S Baker,Adwoa Bentsi-Enchill,Robert F Breiman,Carl Britto,Josefina Campos,Chih-Jun Chen,Chien-Shun Chiou,Viengmon Davong,Abul Faiz,Danish Gul,Rumina Hasan,Mochammad Hatta,Aamer Ikram,Lupeoletalalelei Isaia,Jan Jacobs,Simon Kariuki,Fahad Khokhar,Elizabeth Klemm,Laura MF Kuijpers,Gemma Langridge,Kruy Lim,Octavie Lunguya,Francisco Luquero,Calman A MacLennan,Florian Marks,Masatomo Morita,Mutinta Muchimba,James CL Mwansa,Kapambwe Mwape,Jason M Mwenda,John Nash,Kathleen M Neuzil,Paul Newton,Stephen Obaro,Sophie Octavia,Makoto Ohnishi,Michael Owusu,Ellis Owusu-Dabo,Eun Park,Julian Parkhill,Duy Thanh Pham,Marie-France Phoba,Derek J Pickard,Raphael Rakotozandrindrainy,Pilar Ramon-Pardo,Farhan Rasheed,Assaf Rokney,Priscilla Rupali,Ranjit Sah,Sadia Shakoor,Michelo Simuyand,Arvinda Sooka,Jeffrey D Stanaway,A Duncan Steele,Bieke Tack,Adama Tall,Neelam Taneja,Mekonnen Teferi,Sofonias Tessema,Gaetan Thilliez,Paul Turner,James E Ussher,Annavi Marie Villanueva,Bart Weimer,Vanessa K Wong,Raspail Carrel Founou,Buddha Basnyat
DOI: https://doi.org/10.7554/elife.85867
IF: 7.7
2023-09-13
eLife
Abstract:Salmonella Typhi (Typhi) is a type of bacteria that causes typhoid fever. More than 110,000 people die from this disease each year, predominantly in areas of sub-Saharan Africa and South Asia with limited access to safe water and sanitation. Clinicians use antibiotics to treat typhoid fever, but scientists worry that the spread of antimicrobial-resistant Typhi could render the drugs ineffective, leading to increased typhoid fever mortality. The World Health Organization has prequalified two vaccines that are highly effective in preventing typhoid fever and may also help limit the emergence and spread of resistant Typhi. In low resource settings, public health officials must make difficult trade-off decisions about which new vaccines to introduce into already crowded immunization schedules. Understanding the local burden of antimicrobial-resistant Typhi and how it is spreading could help inform their actions. The Global Typhoid Genomics Consortium analyzed 13,000 Typhi genomes from 110 countries to provide a global overview of genetic diversity and antimicrobial-resistant patterns. The analysis showed great genetic diversity of the different strains between countries and regions. For example, the H58 Typhi variant, which is often drug-resistant, has spread rapidly through Asia and Eastern and Southern Africa, but is less common in other regions. However, distinct strains of other drug-resistant Typhi have emerged in other parts of the world. Resistance to the antibiotic ciprofloxacin was widespread and accounted for over 85% of cases in South Africa. Around 70% of Typhi from Pakistan were extensively drug-resistant in 2020, but these hard-to-treat variants have not yet become established elsewhere. Variants that are resistant to both ciprofloxacin and ceftriaxone have been identified, and azithromycin resistance has also appeared in several different variants across South Asia. The Consortium's analyses provide valuable insights into the global distribution and transmission patterns of drug-resistant Typhi. Limited genetic data were available fromseveral regions, but data from travel-associated cases helped fill some regional gaps. These findings may help serve as a starting point for collective sharing and analyses of genetic data to inform local public health action. Funders need to provide ongoing supportto help fill global surveillance data gaps.
biology